v3.26.1
Note 2 - Summary of Significant Accounting Policies (Details Textual)
6 Months Ended
Jul. 16, 2026
Oct. 21, 2025
Jun. 30, 2026
USD ($)
shares
Dec. 31, 2025
USD ($)
Cash, Uninsured Amount     $ 14,904,167 $ 7,580,820
Research and Development Assets, Current     1,294,081 1,802,228
Impairment, Long-Lived Asset, Held-for-Use     0  
Derivative Liability     $ 22,500 $ 22,500
Minimum [Member]        
Property, Plant and Equipment, Useful Life (Year)     3 years  
Maximum [Member]        
Property, Plant and Equipment, Useful Life (Year)     5 years  
Share-Based Payment Arrangement, Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares     60,213  
Restricted Stock Units (RSUs) [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares     2,564  
Reverse Stock Split [Member]        
Stockholders' Equity Note, Stock Split, Conversion Ratio   50    
Reverse Stock Split [Member] | Subsequent Event [Member]        
Stockholders' Equity Note, Stock Split, Conversion Ratio 22